IGF-I has insulin-like effects, but it appears to be involved in many other functions and has been linked to ageing, nutrition, physical activity and cancer
Assay Designs introduces a human IGF-I Elisa kit to the market.
This immunoassay quantitatively measures levels of human IGF-I in serum and plasma samples.
IGF-I has insulin-like effects, but it appears to be involved in many other functions and has been linked to ageing, nutrition, physical activity and cancer.
While each of these is very interesting on its own, together they may shed light on the role that lifestyle plays in influencing cancer risk.
High levels of circulating IGF-I and low levels of IGF binding protein-3 (IGFBP-3) are associated with increased risk of several cancers.
IGF-I can stimulate cell proliferation and inhibit apoptosis in many different kinds of cells.
The colorimetric 96 well plate format quantitatively measures human IGF-I concentration with a range of 187-6000pg/ml in four hours.
This assay is non-radioactive and comes complete with ready to use, colour-coded liquid reagents.
Assay Designs manufactures immunoassay and detection kits (Elisa kits).
It says its high quality assay kits are fast, sensitive and reliable.
It also carries a selection of luminescent products, antibodies and proteins for research needs.
